Magnesium Supplementation Guidelines

Introduction to Magnesium Bioavailability

Organic magnesium salts, such as citrate, aspartate, and lactate, have higher bioavailability than inorganic compounds like magnesium oxide or hydroxide, according to Praxis Medical Insights 1, 2

The American Gastroenterological Association recommends magnesium oxide 1.5 g/day for chronic idiopathic constipation, though lower doses of 500 mg-1 g/day are commonly used in practice 3
Magnesium oxide resulted in no differences compared to placebo in bioavailability studies, despite containing more elemental magnesium per dose, and primarily works through osmotic effects in the GI tract rather than systemic absorption 3, 4
Intestinal absorption of magnesium is typically 35-50%, making the choice of highly bioavailable forms critical 5, 6

The American College of Gastroenterology recommends using magnesium citrate at 12-24 mmol daily as first-line therapy for mild hypomagnesemia 1, 2
Administering magnesium at night when intestinal transit is slowest can maximize absorption 1
Avoid magnesium supplementation in patients with creatinine clearance <20 mg/dL due to hypermagnesemia risk 3, 4

Reducing excess dietary lipids can help improve magnesium absorption 1
Monitor for secondary electrolyte abnormalities, particularly potassium and calcium, which often accompany hypomagnesemia 2

Magnesium oxide is insoluble in water and alcohol but dissolves in dilute gastric acid, converting to magnesium chloride in the stomach, which is necessary for any absorption to occur, according to the European Society of Gastrointestinal Endoscopy 7
The small intestine typically absorbs 30-50% of magnesium intake under basal conditions, but magnesium oxide falls far below this range, as noted by the European Society of Clinical Nutrition 8

Magnesium oxide is commonly prescribed at 12-24 mmol daily (approximately 480-960 mg elemental magnesium) in patients with short bowel syndrome or jejunostomy, given as gelatin capsules of 4 mmol (160 mg) each, as recommended by the European Society of Gastroenterology 7
Administration at night when intestinal transit is slowest maximizes the limited absorption that does occur, according to the European Society of Gastrointestinal Endoscopy 7
The small amount of magnesium oxide that is absorbed is sufficient for some clinical benefit in hypomagnesemia when combined with correction of water and sodium depletion, as noted by the European Society of Gastroenterology 7
If oral magnesium oxide fails to normalize magnesium levels, alternative strategies include switching to more bioavailable organic salts or providing intravenous/subcutaneous magnesium, as recommended by the European Society of Gastroenterology 7

Magnesium bisglycinate demonstrates superior absorption compared to inorganic forms, with intestinal absorption typically ranging 35-50% for magnesium compounds, according to Clinical Nutrition 9

Organic chelated forms like bisglycinate show significantly better bioavailability than magnesium oxide in head-to-head studies, although the exact study is not specified 9